Cambridge Archives - PharmaLive

Merck’s Acceleron Integration To Take Out 143 Jobs in Cambridge, MA

Anemia, Blockbusters, Blood Vessels, Business, Cambridge, Clinical Trials, Committee for Medicinal Products for Human Use (CHMP), Erythroid maturation agents, First-In-Class, Job Cuts, Keytruda, Massachusetts, Pulmonary Arterial Hypertension, R&D, Royalties, Therapeutics, Transforming Growth Factor-beta (TGFb)

Merck announced that the company will lay off 170 people from Cambridge, Massachusetts-based Acceleron Pharma, which was acquired during November 2021 for about $11.5 billion.

March 30, 2022/by BioSpace